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Activation of human platelets with thrombin transiently increases phosphorylation at 558threonine of
moesin as determined with phosphorylation state-specific antibodies. This specific modification is
completely inhibited by the kinase inhibitor staurosporine and maximally promoted by the phospha-
tase inhibitor calyculin A, making it possible to purify the two forms of moesin to homogeneity. Blot
overlay assays with F-actin probes labeled with either [32P]ATP or 125I show that only phosphorylated
moesin interacts with F-actin in total platelet lysates, in moesin antibody immunoprecipitates, and
when purified. In the absence of detergents, both forms of the isolated protein are aggregated.
Phosphorylated, purified moesin co-sediments with a- or b/g-actin filaments in cationic, but not in
anionic, nonionic, or amphoteric detergents. The interaction affinity is high (Kd, ;1.5 nM), and the
maximal moesin:actin stoichiometry is 1:1. This interaction is also observed in platelets extracted with
cationic but not with nonionic detergents. In 0.1% Triton X-100, F-actin interacts with phosphorylated
moesin only in the presence of polyphosphatidylinositides. Thus, both polyphosphatidylinositides
and phosphorylation can activate moesin’s high-affinity F-actin binding site in vitro. Dual regulation
by both mechanisms may be important for proper cellular control of moesin-mediated linkages
between the actin cytoskeleton and the plasma membrane.
§ Corresponding author. E-mail address: hfurthmayr@pathology.
stanford.edu.
Abbreviations used: 558T-p-moesin, moesin phosphorylated at the 558T
site; DEAE, diethylaminoethyl; DOTMAC, dodecyltrimethylammonium
chloride; KYKpTLR and KYKTLR, phosphorylated and nonphosphory-
lated peptides; LysoPC:diC12:0, l-a-phosphatidylcholine dilauroyl;
LysoPC:C16:0, l-a-phosphatidylcholine dipalmytoyl; mAbMo, mono-
clonal moesin antibodies; np-moesin, nonphosphorylated moesin;
pAbKYKpTLR, affinity-purified polyclonal antibodies specific for phos-
phorylated moesin; pAbMo, affinity-purified polyclonal moesin antibod-
ies; PGE1, prostaglandin E1; PG:diC16, l-a-phosphatidyl-dl-glycerol di-
palmitoyl sodium salt; PA:diC16:0, l-a-phosphatidic acid dipalmitoyl
sodium salt; PI, l-a-phosphatidylinositol sodium salt; PI(3)P:diC16:0,
l-a-phosphatidylinositol 3-phosphate dipalmitoyl; PI(4)P, l-a-phospha-
tidylinositol 4-phosphate; PI(3,4)P2:diC16:0, l-a-phosphatidylinositol 3,4-
biphosphate dipalmitoyl; PI(4,5)P2, l-a-phosphatidylinositol 4,5-biphos-
phate; PI(3,4,5)P3:diC16:0, l-a-phosphatidylinositol 3,4,5-triphosphate
dipalmitoyl; PIPx, phosphatidylinositol polyphosphate; PMA, phorbol
12-myristate 13-acetate.
INTRODUCTION
Moesin, ezrin, and radixin have been proposed to function
as linkages between the plasma membrane and F-actin in the
cortex of cells. Structurally, these proteins are composed of
three major regions: an N-terminal domain of ;300 amino
acid residues consisting of several discrete subdomains with
amino acid sequences that are identical in the three proteins
across a wide variety of species, a 150-amino-acid long se-
quence predicted to form central a-helices, and a short C-
terminal domain of ;100 amino acid residues that includes
a conserved sequence of ;30 residues at the C-terminal end
(Gould et al., 1989; Tsukita et al., 1989; Funayama et al., 1991;
Lankes and Furthmayr, 1991; Lankes et al., 1993). Function-
ally, the N-terminal domain has been associated with bind-
ing to membrane constituents, as revealed by its distribution
in cellular microextensions, its localization after transfection
with DNA expression constructs (Algrain et al., 1993;
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Amieva et al., 1998), and its direct interaction with mem-
brane proteins (Hirao et al., 1996; Yonemura et al., 1998),
adapter proteins containing the PDZ motif (Reczek et al.,
1997; Short et al., 1998), and polyphosphatidylinositides
(Niggli et al., 1995). Likewise, binding of the C-terminal
domain to actin filaments has been established by co-distri-
bution with stress fibers (Algrain et al., 1993; Amieva et al.,
1998) and by in vitro binding data with fragments contain-
ing the entire domain (Turunen et al., 1994; Pestonjamasp et
al., 1995; Matsui et al., 1998). F-actin binding studies with
full-length native proteins have yielded less consistent re-
sults. Earlier work could not demonstrate this activity, but
recently, Yao et al. (1996) demonstrated high-affinity and
preferential binding of ezrin purified from gastric parietal
cells to b-actin and suggested that this activity depends on
phosphorylation. More recent studies, using in vitro phos-
phorylation by PKC-theta of recombinant and/or partially
purified ezrin and moesin, also produced evidence for a
phosphorylation-dependent interaction (Pietromonaco et al.,
1998; Simons et al., 1998).
N-terminal recombinant fragments of ;300 amino acid
residues of ezrin and radixin bind ;100-residue C-terminal
fragments (Gary and Bretscher, 1995; Magendantz et al.,
1995). This has given rise to the concept that full-length
molecules are stabilized by an intramolecular interaction
between the two domains.
We recently showed that activation of human platelets
with thrombin is associated with a rapid and transient 1.5-
fold increase in the phosphorylation of a single threonine
residue in position 558 of the moesin sequence (Nakamura et
al., 1995). Phosphorylation at this site could be inhibited
with the phosphokinase inhibitor staurosporine and maxi-
mally enhanced with the phosphatase inhibitor calyculin A.
Both treatments were accompanied by characteristic mor-
phological changes of the platelet. Phosphorylation of the
same residue was confirmed in other cells in that lysophos-
phatidic acid treatment of serum-starved Swiss 3T3 cells
changed the phosphorylation state of moesin, ezrin, and
radixin with similar kinetics (Matsui et al., 1998), as did
stimulation of mast cells, macrophages, and NIH3T3 cells
(Ichimaru and Furthmayr, unpublished results; Nakamura
et al., 1996; Nakamura and Furthmayr, unpublished results).
The mechanism for lysophosphatidic acid-stimulated phos-
phorylation of moesin apparently involved activation of the
small GTPase Rho and its downstream kinase, Rho kinase,
because Rho kinase efficiently phosphorylated two residues
564Thr (558Thr in moesin) and 573Thr of a C-terminal frag-
ment of radixin in vitro. However, Rho-kinase did not phos-
phorylate the full-length native protein. Phosphorylation of
the C-terminal threonine residues prevented this domain
from interacting with the N domain but did not change the
inherent F-actin binding ability of the fragment (Matsui et
al., 1998). The fact that Rho kinase did not phosphorylate the
full-length protein suggested either that a different kinase
acts in vivo or that additional regulatory steps or factors are
necessary.
In the present study we tested the hypothesis that the
F-actin binding function of moesin is activated during stim-
ulation of platelets by phosphorylation of the single threo-
nine residue (558Thr) that we had identified earlier. The
platelet system allowed us to isolate and purify both the
unmodified and phosphorylated cellular form of moesin to
homogeneity for biochemical and functional studies with
F-actin blot overlay and co-sedimentation assays. In contrast
to reports from other laboratories with recombinant and/or
partially purified cellular proteins, we found that both phos-
phorylation of 558Thr and the presence of either polyphos-
phoinositides or a cationic detergent is required for the
F-actin binding activity of moesin. This result suggests a
more complex two-step regulatory mechanism for the acti-
vation of the high-affinity F-actin binding site.
MATERIALS AND METHODS
Antibodies and Lipids
Mouse monoclonal antibody 38/87 and the affinity-purified poly-
clonal antibody pAbMo were used for the identification of moesin
by immunoblotting and for immunoprecipitation, respectively
(Amieva and Furthmayr, 1995). The affinity-purified polyclonal an-
tibodies pAbKYKpTLR and pAbKYKTLR were prepared as de-
scribed previously (Nakamura et al., 1996). Actin monoclonal anti-
bodies were purchased from Sigma (St. Louis, MO). PG:diC16:0 and
PA:diC16:0 were purchased from Wako Pure Chemical Industries
(Osaka, Japan). PI(3)P:diC16:0, PI(3,4)P2:diC16:0 and PI(3,4,5)P3:
diC16:0 were purchased from Matreya (Pleasant Gap, PA). Bovine
brain-derived PI(4)P, PI(4,5)P2 and PI(1,4,5)P3 were purchased from
Boehringer Mannheim (Mannheim, Germany) or Sigma. Other
lipids derived from bovine brain, unless noted, were purchased
from Sigma. Micelles of PI(3,4)P2:diC16:0, PI(4,5)P2:diC16:0, and
PI(3,4,5)P3:diC16:0 were prepared by dissolving in HE (20 mM
Hepes-NaOH, pH 7.2, 0.2 mM EGTA, 0.2 mM EDTA) as a stock
solution of 1 mg/ml. These lipids were well soluble, whereas other
phosphatidylinositol polyphosphates needed to be sonicated. Small
unilamellar vesicles were prepared from lipids by sonication in a
Branson (Danbury, CT) cup sonicator, intensity setting 5, at 50%
duty cycle, for 9 min (3 3 3 min) to a stock solution of 1 mg/ml in
HE. Multilamellar vesicles were prepared from lipids as a stock
solution of 1 mg/ml in HE as described (Hope et al., 1986).
Isolation and Activation of Platelets in Suspension
Human blood platelets were prepared as described previously (Na-
kamura et al., 1995). Gel-filtered platelets were resuspended in Ty-
rode’s buffer (136 mM NaCl, 2.9 mM KCl, 12 mM NaHCO3, 0.36 mM
NaH2PO4, 1.8 mM CaCl2, 0.4 mM MgCl2, 5.5 mM glucose, pH 7.4)
at 1 3 109 platelets/ml. Platelets were activated by the addition of
1.0 NIH unit of thrombin/ml, 1 mM phorbol 12-myristate 13-acetate
(PMA), 1 mM calcium ionophore A23187, or 5 mM prostaglandin E1
(PGE1). For some experiments, platelets were incubated for 10 min
with 100 nM calyculin A or 1 mM staurosporine. All experiments
were performed at 37°C.
Gel Electrophoresis and Western Blotting
Platelets were lysed by addition of an equal volume of 23 SDS
sample buffer (125 mM Tris-HCl, 4% SDS, 20% glycerol, 10% 2-mer-
captoethanol, pH 6.8). Moesin was immunoprecipitated from ly-
sates of platelets as described previously (Nakamura et al., 1995).
Polypeptides were separated by SDS-PAGE on a 9.0% polyacryl-
amide gel under reducing conditions. Phosphorylated (558T-p-) or
nonphosphorylated (np-) moesin was detected by immunoblotting
with affinity-purified pAbKYKpTLR and pAbKYKTLR antibodies
and the enhanced chemiluminescence detection system (Amersham,
Arlington Heights, IL).
Purification of Phosphorylated and
Nonphosphorylated Moesin from Human Platelets
Platelets in Tyrode’s buffer were incubated for 10 min at 37°C with
100 nM calyculin A or 1 mM staurosporine for the isolation of
F. Nakamura et al.
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phosphorylated or unphosphorylated moesin, respectively. The
pretreated platelets were then lysed by addition of 10 volumes of
buffer A (20 mM Tris-HCl, 0.5 mM EDTA, 0.5 mM EGTA, 10 mM
2-mercaptoethanol, pH 7.5) containing 1% Triton X-100, proteinase
inhibitors (100 mg/ml leupeptin, 1 mM PMSF, 100 mM benzami-
dine), and phosphatase inhibitors (100 nM calyculin A, 40 mM
sodium pyrophosphate, 10 mM phenyl arsine oxide). After centrif-
ugation at 25,000 3 g for 60 min at 4°C, moesin was isolated and
purified from the supernatant by several chromatographic steps in
the order listed below. All purification procedures were performed
at 4°C. During each step, fractions containing phosphorylated and
unphosphorylated moesin were identified by immunoblotting with
affinity-purified pAbKYKpTLR and pAbKYKTLR antibodies (Na-
kamura et al., 1996).
Heparin-Agarose Chromatography. The supernatant was loaded
onto a heparin-agarose column (15 3 57 mm, Sigma, St. Louis, MO),
pre-equilibrated with buffer B (buffer A containing 1 mM PMSF and
40 mM sodium pyrophosphate), and developed with a 200-ml linear
gradient of 0–500 mM NaCl in the equilibrating buffer at a flow rate
of 1 ml/min. Fractions, containing np-moesin (72–92 ml) or 558T-p-
moesin (100–116 ml), were pooled and diluted 1:2 with buffer B.
Blue-Sepharose Chromatography. The pooled fractions from step 1
were loaded onto a blue-Sepharose CL-6B fast flow column (15 3 57
mm; Pharmacia, Piscataway, NJ), preequilibrated with buffer B.
Moesin was eluted with a linear salt gradient (200 ml) from 0 to 800
mM NaCl in buffer B at a flow rate of 1 ml/min. Fractions, contain-
ing np-moesin (132–156 ml) or 558T-p-moesin (140–164 ml) were
pooled, and NaCl was added to 1 M final concentration.
Phenyl-Sepharose Chromatography. Phenyl-Sepharose CL-4B col-
umn (15 3 57 mm; Pharmacia) was washed with ethanol, followed
by buffer B containing 1 M NaCl. After loading the sample from step
2, the column was washed with 100 ml of buffer A at 1 ml/min.
Moesin was eluted with buffer A containing 1% Triton X-100. Frac-
tions containing moesin (20–28 ml) were pooled.
Diethylaminoethyl (DEAE) Cellulose Chromatography. The pooled
fractions from step 4 were loaded onto a DEAE-cellulose column
(15 3 57 mm, Whatman, Maidstone, England; DE52), equilibrated
with 5 mM Tris-HCl, pH 7.5, 0.01% sodium azide. Moesin was
eluted with a linear salt gradient (200 ml) from 0 to 400 mM KCl in
the equilibrating buffer at a flow rate of 1 ml/min. Fractions con-
taining moesin (30–42 ml) were pooled and dialyzed against buffer
M (5 mM Tris-HCl, pH 7.5, 150 mM KCl, 0.01% sodium azide).
When other proteins, especially actin, contaminated the prepara-
tions, further purification was performed by gel filtration chroma-
tography on Superose 12HR10/30 (10 3 300 mm; Pharmacia) equil-
ibrated with 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.005% Triton
X-100. This step was usually needed, particularly when columns in
steps 1–4 had been reused. The highly purified preparations were
finally stored at 4°C.
Purification of Actin Isoforms
a-Actin was prepared from rabbit skeletal muscle with some mod-
ifications of a previously published procedure (Spudich and Watt,
1971). Actin was extracted from acetone powder in buffer G (2 mM
Tris-HCl, 0.2 mM CaCl2, 0.2 mM DTT, 0.2 mM ATP, 0.005% sodium
azide) and cycled through one round of polymerization. After cen-
trifugation at 100,000 3 g, F-actin was resuspended in buffer G and
rechromatographed on Superdex 200pg (1.6 3 600 mm; Pharmacia).
Platelet actin was prepared as previously described (Gordon et al.,
1977). DEAE-cellulose (Whatman, DE52), 200 ml (wet volume), was
washed with 1 N HCl, 1 N NaOH, and water (2000 ml each) and
then suspended in ;200 ml of buffer C (10 mM Tris-HCl, 0.2 mM
Na2ATP, 0.2 mM CaCl2, 0.5 mM DTT, 0.005% sodium azide) con-
taining 100 mM KCl. ATP (1.2 g) was added, and the pH was
readjusted to 7.5 with KOH. After 15 min the ATP-saturated DEAE-
cellulose was packed into a column (2.5 3 30 cm) and equilibrated
with 400 ml of 100 mM KCl in buffer C. Washed human platelets
(2 3 1011) were homogenized in 20 ml of buffer G and centrifuged
for 90 min at 100,000 3 g at 4°C. The extract was chromatographed
on the DEAE-cellulose column. Forty milliliters of buffer G were
applied immediately before and after the sample. The column was
then eluted with 200 ml of 100 mM KCl in buffer C and 2 l of a linear
gradient from 100 to 500 mM KCl in buffer C at 1 ml/min. Actin
eluted between 190 and 240 mM KCl. Two-micromolar MgCl2 was
added, and the solution was warmed to 25°C for 60 min to poly-
merize actin. After centrifugation at 100,000 3 g for 3 h at 20°C, the
pellet was homogenized in 20 ml of buffer G. The suspension was
then dialyzed against three changes of buffer G for 60 h. Residual
material was removed by centrifugation at 100,000 3 g for 90 min,
and the depolymerized actin was applied to Superdex 200pg and
eluted with buffer G. Actin-containing fractions were pooled in
buffer G containing 2 mM MgCl2 and 100 mM KCl to polymerize
actin. After pelleting at 100,000 3 g, F-actin was resuspended in
buffer G and rechromatographed on Superdex 200pg.
F-Actin Overlay Assay
Platelets were lysed by addition of an equal volume of 23 SDS
sample buffer at 70°C for 5 min. The samples were resolved by
SDS-PAGE on a 9%, 0.75-mm-thick polyacrylamide gel run under
reducing conditions at constant 120 V for 100 min at 20–25°C. The
proteins were electrotransferred to nitrocellulose membranes (BA-
85, 0.45 mm pore size; Schleicher & Schuell, Keene, NH) at constant
5 mA/cm2 for 60 min at room temperature using a semidry blotting
apparatus (KS-8460; Marysol, Tokyo, Japan). Nitrocellulose blots
were incubated overnight at 4°C in TTBS (20 mM Tris-HCl, pH 7.6,
137 mM NaCl, 0.05% Tween 20) containing 0.01% sodium azide to
renature proteins and were blocked in 5% milk in TTBS for either 1 h
at room temperature or overnight at 4°C before shipment from
Japan to the United States.
The blots were blocked a second time with 5% milk, 90 mM NaCl,
0.05% (vol/vol) Tween 20, 10 mM Tris-HCl, pH 7.5 (TBST) and
probed with 50 mg/ml gelsolin-capped, phalloidin-stabilized, 125I-
labeled F-actin in TBST (Chia et al., 1991). The blot was washed four
or five times (2 min/wash) with TBST, air dried, and exposed either
at 21°C to a phosphoimager screen or at 280°C to film in the
presence of an intensifying screen. Alternatively, the blots were
probed with 20 mg/ml phalloidin-stabilized [a-32P]ATP, prepared
as described by Mackay et al. (1997) and Huang et al. (1999).
F-Actin Co-Sedimentation Assay in the Presence of
Liposomes
F-actin was incubated with or without 558T- or np-moesin in buffer
F (5 mM Tris-HCl, pH 7.5, 0.5 mM Na2ATP, 2 mM MgCl2, 140 mM
NaCl, 0.2 mM DTT, 0.2 mM CaCl2, 0.005% sodium azide) with or
without various liposomes for 1 h at 37°C. In some experiments,
lysoPC or Triton X-100 was added to the reaction mixture during
the incubation. The filaments were then sedimented by centrifuga-
tion at 100,000 3 g for 20 min at 37°C. Proteins in the supernatants
and pellets were then solubilized in SDS gel sample buffer and
subjected to SDS-PAGE. Polypeptides in the gel were visualized by
Coomassie brilliant blue staining.
Gel Shift Assay by SDS-PAGE
Phosphorylated or nonphosphorylated moesin (0.5 mg), or a-actin
(0.5 mg) was incubated with various lipid vesicles (prepared with or
without sonication; final concentration, 0.02%, wt/vol) in buffer F
(final volume, 10 ml) for 1 h at 37°C. For this assay, lipids were
solubilized in water. In some experiments, after incubation with
lipids, detergents (0.1%, unless noted otherwise, or 1%, wt/vol) or
phospholipid (0.02%, wt/vol) were added, and the incubation was
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continued at 37°C for 10 or 60 min. The reaction mixtures were then
mixed with an equal volume of 23 SDS sample buffer and either
heated for 10 min at 95°C or immediately loaded onto a 9% poly-
acrylamide gel (1 mm thick) and electrophoresed under reducing
conditions at constant 160 V for 70 min at room temperature in a
Hoefer SE250 minigel apparatus. Polypeptides in the gel were vi-
sualized by silver staining.
Affinity Precipitation Assay with Biotinylated
Synthetic Peptides
Two biotinylated peptides of the following sequences from the
C-terminal domain of CD44 were synthesized, purified, and char-
acterized by mass spectroscopy by the Protein Chemistry Facility at
Tufts University: biotin, IAVNSRRRCGQKKKLVINS (CD44cyt);
and biotin, IAVNSAARCGQKKKLVINS (CD44cytAA, mutated
control). Each peptide (2.5 mg) was added in 50 ml of buffer F and
incubated with 10 ml of streptavidin-agarose 1:1 slurry for 1 h. After
two washes with buffer F, 558T-p- or np-moesin (0.5 mg each) was
added and incubation was continued in the presence or absence of
lipids (0.01%, wt/vol), with or without 0.1% (wt/vol) Triton X-100,
for an additional 1 h. In some experiments, F-actin (2 mg) was
added, and the mixture was incubated for 1 h. All incubations were
performed at 37°C. The beads were pelleted, and supernatants were
removed. Bound proteins were eluted from the beads by boiling in
SDS sample buffer and analyzed on 9% silver-stained SDS-PAGE
gels.
F-Actin Co-Sedimentation Assay in the Presence of
Detergents
F-actin was incubated for 1 h at 25°C with (or without) 558T-p- or
np-moesin in buffer F and with or without various detergents. For
some experiments, F-actin was incubated with phalloidin at molar
ratios (actin/phalloidin) from 0.5 to 5 for 30 min at 25°C before
addition of detergent and moesin. The filaments were then sedi-
mented by centrifugation at 100,000 3 g for 20 min at 25°C. Proteins
in the supernatants and pellets were solubilized in SDS gel sample
buffer and analyzed after SDS-PAGE and silver staining.
To determine the stoichiometry of moesin/F-actin binding, F-
actin was incubated with phalloidin at a 1:2 (actin/phalloidin)
molar ratio for 30 min at 25°C before addition of detergents with (or
without) 558T-p- or np-moesin in buffer FK (5 mM Tris-HCl, pH 7.5,
0.5 mM Na2ATP, 2 mM MgCl2, 140 mM KCl, 0.2 mM DTT, 0.2 mM
CaCl2, 0.005% sodium azide). Incubations were continued for 1 h at
25°C. The actin filaments were sedimented by centrifugation at
100,000 3 g for 20 min at 25°C. Proteins in the supernatants were
precipitated with trichloroacetic acid containing 2 mg/ml sodium
deoxycholate, and the precipitates were washed with ice-cold ace-
tone, dissolved in SDS sample buffer, separated by SDS-PAGE, and
analyzed by Coomassie blue staining or by immunoblotting with
affinity-purified pAbMo or pAbKYKpTLR.
Isolation of DOTMAC- and Triton X-100-Insoluble
Fractions
Platelets were lysed by adding an equal volume of 23 dodecyltri-
methylammonium chloride (DOTMAC; Nacalai Tesque, Kyoto, Ja-
pan) lysis buffer (2% DOTMAC, 50 mM Tris-HCl, 10 mM EGTA, 100
mM NaCl, 2 mM MgCl2, protease inhibitor mixture [20 mg/ml
aprotinin, 20 mM E-64, 200 mM leupeptin, 200 mM p-amidinophe-
nylmethanesulfonyl fluoride], 1 mM calyculin A, 5 mM sodium
pyrophosphate, 1 mM staurosporine, 100 mM pervanadate, 10 mM
phalloidin, 10 mg/ml Taxol). After 5 min on ice, the lysates were
centrifuged at 15,600 3 g for 4 min at 4°C. The resulting pellet (15K
pellet) was solubilized in 13 SDS sample buffer. The 15K superna-
tant was centrifuged again at 100,000 3 g for 30 min at 4°C, and
proteins in pellets (100K pellet) and supernatants were solubilized
with SDS sample buffer. For the Triton X-100 fractionation, 2% of
Triton X-100 was used instead of DOTMAC, and all other proce-
dures were essentially identical. All samples were heated at 95°C,
sonicated, and resolved by SDS-PAGE on a 10% polyacrylamide gel
electrophoresed under reducing conditions as described (Nakamura
et al., 1995). Moesin, phosphorylated moesin, and actin were de-
tected by immunoblotting and the enhanced chemiluminescence
detection system.
Quantitation of Moesin
Amounts of 558T-p- and np-moesin were determined from the in-
tensity of the bands on immunoblots developed with the antibodies
described above using scanning densitometry and known amounts
of recombinantly prepared moesin as the standard. Quantification
was performed on blots prepared in parallel to blots used for F-actin
binding experiments.
RESULTS
Phosphorylation of Moesin in Human Platelets
Stimulation of human platelets with thrombin is accompa-
nied by a transient incorporation of 32Pi into moesin at a
single amino acid residue, 558threonine (Nakamura et al.,
1995). Subsequent to the initial observation, we prepared
phosphorylation state-specific antibodies to both phosphor-
ylated and nonphosphorylated synthetic peptides contain-
ing 558T (Nakamura et al., 1996). The antibodies to the phos-
phorylated form of the peptide were more useful because
of higher titers and greater specificity. This reagent
(pAbKYKpTLR) reacted only with phosphorylated moesin,
either immunoprecipitated from lysates of untreated plate-
lets or platelets treated with calyculin A (Figure 1). The
antibody was essentially unreactive with nonphosphory-
lated moesin isolated from staurosporine-treated platelets
and also failed to react with any other protein in whole
platelet lysates. Thus, the epitope recognized by this anti-
body is not shared by any other platelet protein. Consistent
with the time course of phosphorylation established earlier
using 32Pi incorporation into moesin is the Western blot
analysis of platelet lysates shown in Figure 1B. Given equiv-
alent loading of lysates for each time point and assuming
100% phosphorylation of moesin in calyculin A-treated
platelets (Nakamura et al., 1995), the percentage of phos-
phorylated moesin molecules was calculated from the rela-
tive intensity of the moesin signal observed with
pAbKYKpTLR. In resting platelets, ;25% of the moesin
molecules were phosphorylated. This number varied some-
what depending on individual platelet preparations but was
not significantly influenced by platelet storage. Although
many of the experiments were performed with platelets
isolated from outdated platelet-rich plasma, similar data
were obtained with freshly prepared platelets. Within sec-
onds after exposure to thrombin, a 1.3-fold increase to ;35%
in the number of 558T-p-moesin molecules was observed,
and this number decreased to ;15% within 1–2 min.
Platelets are quite sensitive to a variety of drugs. For
instance, the phorbol ester PMA, the calcium ionophore
A23187, and prostaglandin PGE1 have been used extensively
to study the mechanism of platelet activation. PMA and
calcium ionophore A23187 activate protein kinase C (Kaibu-
chi et al., 1983; Sano et al., 1983); both treatments caused a
transient increase in moesin phosphorylation (data not
shown). On the other hand, PGE1, which elevates cAMP
F. Nakamura et al.
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levels in the cytosol and inhibits platelet activation, led to
rapid dephosphorylation of moesin within 1 min. These
results suggest that phosphorylation of moesin correlates
with the state of platelet activation, which may be influenced
by different kinases and phosphatases depending on the
nature of the stimulus.
Isolation of Phosphorylated and Nonphosphorylated
Moesin from Human Platelets
When stimulated with thrombin or when exposed to a sur-
face such as glass, platelets change shape by spreading and
by protruding filopodia, characteristic extensions of the
plasma membrane that contain moesin and actin filaments
(Nakamura et al., 1995). To address the relationship between
phosphorylation of moesin and binding to actin filaments
more directly, np- and 558T-p-moesin were purified from
human platelets that had been pretreated with staurosporine
or calyculin A, respectively. Figure 2A shows the first puri-
fication step on heparin-agarose for moesin from platelets
treated with 100 nM calyculin A for 30 s. These conditions
induced phosphorylation of ;50% of total moesin as con-
firmed by immunoblotting (our unpublished data). Moesin
eluted in two major peaks at 190–220 mM NaCl and 260–290
mM NaCl, respectively (Figure 2B). Monoclonal anti-moesin
and pAbKYKTLR antibodies reacted with both forms of
moesin (Figure 2B). When lysates of staurosporine-treated
platelets were analyzed, the second peak was completely
eliminated (our unpublished data), and this peak became the
major peak in calyculin A-treated platelets. The first peak con-
tains only np-moesin, and the second contains exclusively 558T-
p-moesin, as confirmed with the pAbKYKpTLR antibody re-
agent (Figure 2, B–D). The purification scheme for 558T-p- and
np-moesin included sequential chromatography on columns of
blue Sepharose, phenyl-Sepharose, and DEAE-cellulose ion ex-
change chromatography (details in MATERIALS AND METH-
ODS). 558T-p-moesin was considerably enriched after the blue-
and phenyl-Sepharose steps and was a single Coomassie blue-
stained band after final purification on DEAE-cellulose (Figure
2E). Similar data were obtained for np-moesin, and the final
purified preparations proved to be homogeneous by silver
staining (our unpublished results) and two-dimensional elec-
trophoresis (Figure 2F). No differences in properties were seen
by gel permeation chromatography or sucrose gradient centrif-
ugation in 0.1% Triton X-100 or 0.1% DOTMAC. Both forms of
moesin appeared to be monomeric, indicating that no detect-
able changes in moesin association state accompanied phos-
phorylation.
Phosphorylated Moesin Binds Actin Filaments by
Blot Overlay
Using the two highly purified and well-characterized forms
of platelet moesin, we asked whether phosphorylation of
558threonine affects moesin binding to rabbit skeletal muscle
a- and b/g-actin from platelets in vitro. b-Actin was chosen
because this isoform is localized in subcortical regions of
cells and because a preference for this isoform was reported
in experiments with ezrin isolated from gastric parietal cells.
As shown in Figure 3A, F-actin bound weakly on blot
overlays to purified platelet np-moesin and strongly to 558T-
p-moesin. F-actin binding of moesin was also increased in
platelets that had been activated with thrombin or pre-
treated with calyculin A; increased F-actin binding corre-
lated well with the increased amounts of 558T-p-moesin
molecules (Figure 3B). Whether labeled directly with the
125I-Bolton–Hunter method (Figure 3B) or indirectly by in-
corporation of [32P]ATP during polymerization (Figure 3C),
the F-actin probe usually bound weakly to recombinant
moesin and to moesin from staurosporine-treated platelets.
Increases and decreases in F-actin binding on overlays
closely followed the kinetic response of moesin phosphory-
lation upon thrombin stimulation (our unpublished results).
Resting platelets and platelets treated with staurosporine
gave somewhat variable results. Although in some experi-
ments a signal was not detectable in staurosporine-treated
Figure 1. Detection and quantification of moesin phosphorylation
at a single site, 558threonine, in platelets by immunoblot analysis.
(A) Immunoblot analysis with mouse monoclonal antibody
(mAbMo) 38/87 of moesin immunoprecipitated with a polyclonal
affinity purified anti-moesin reagent (pAbMo) from detergent ex-
tracts (Ip) and total platelet lysates: untreated (u), 100 nM calyculin
A (CA), or 1 mM staurosporine (ST) pretreated for 10 min. (B)
Immunoblot analysis with rabbit polyclonal anti-558T-p-moesin
raised to the peptide (pAbKYKpTLR) of the same samples as in A.
The position of moesin is indicated with an arrow. The amounts of
moesin in each of the three lanes of Ip and lysates are approximately
the same (A). Note in B the increase in phosphorylation in the CA
samples and the absence of a phosphorylated band in the ST sam-
ples in comparison with untreated platelets. The two dense bands in
the Ip lanes of B are heavy- and light-chain polypeptides of rabbit
IgG in the immunoprecipitate. (C) Immunoblot analysis of moesin
phosphorylation in response to thrombin stimulation of platelets.
Aliquots of total platelet lysates were electrophoresed on 9% SDS-
polyacrylamide gels and blotted after protein transfer to nitrocellu-
lose with pAbKYKpTLR antibodies as in B. ST and CA refer to
lysates from platelets pre-treated with staurosporine or calyculin A
as in A. Molecular mass standards are shown on the left. The blot is
representative of three separate experiments.
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platelet lysates (Figure 3C), in other experiments the signal
was as strong as that shown in Figure 3B. Variations in
protein amount can be excluded, because Western blotting
with antibodies was used for every experiment, and there
was no indication of protein loss during transfer. Detection
of the F-actin binding activity of moesin in the blot overlay
assay depends on protein concentration but could also be
sensitive to factors that impact denaturation and renatur-
ation of the protein on the nitrocellulose filter. This is the
case under certain conditions, because precipitation with
acetone considerably increased F-actin binding to nonphos-
phorylated moesin (our unpublished results). The example
shown in Figure 3C is, however, entirely consistent with a
rather close correlation between F-actin binding signal and
the amount of 558T-p-moesin but not the amount of total
moesin. This result suggests that secondary structural ele-
ments that can regulate the moesin interaction with F-actin
are normally retained, or regained, after SDS-PAGE and
electrotransfer to nitrocellulose.
Co-Sedimentation of F-Actin and 558T-p-Moesin in
Cationic Detergents
We also examined the interaction between purified moesin
and F-actin by co-sedimentation. Both forms of platelet moe-
sin tended to aggregate, and .60% of each form sedimented,
even in the absence of F-actin. We screened a number of
detergents, searching for conditions that maintained moesin
in solution, had a negligible effect on actin filament stability,
and facilitated moesin association with F-actin (Table 1).
Although moesin solubility was achieved with a number of
nonionic, anionic, or amphoteric detergents, both below and
above their critical micelle concentration (Igarashi, 1987), we
found that the best conditions for this assay included the
cationic detergents cetyltrimethylammonium chloride or
DOTMAC. In these detergents, 558T-p-moesin pelleted spe-
cifically with F-actin (Figure 4). No interaction between F-
actin and either form of moesin was observed in any con-
centration of Triton X-100 or other nonionic or amphoteric
detergent (our unpublished results).
558T-p-Moesin and F-actin Associate with High
Affinity
In 0.1% DOTMAC, much more p-moesin than np-moesin
co-sedimented with F-actin (Figure 4A). However, this con-
centration of DOTMAC had a slight effect on actin filaments,
because the amount of actin remaining in the supernatant
was increased relative to that observed in experiments per-
formed in the absence of detergent (our unpublished re-
sults). When phalloidin was added at a 1:2 (actin:phalloidin)
ratio, little or no actin remained in the high-speed superna-
Figure 2. Purification of 558T-phosphorylated and unphosphorylated moesin from human platelets. Human platelets were treated with 100
nM calyculin A for 30 s at 37°C, which produces ;50% of phosphorylated moesin (p-moesin). A cell lysate was prepared as described in
MATERIALS AND METHODS and loaded onto a heparin-agarose column (15 3 57 mm). Proteins were eluted with a 200-ml linear gradient
of 0–500 mM NaCl in equilibrating buffer at a flow rate of 1 ml/min, and fractions of 4 ml were collected and analysed by SDS-PAGE (A;
CBB, Coomassie brilliant blue–stained gel) and immunoblot analysis (B–D). Analysis of fraction numbers 18–31 is shown, and a lysate of
calyculin A-treated platelets served as the positive control in lane 1 (CA). Blots were developed with monoclonal moesin antibodies (B;
mAbMo) and affinity-purified polyclonal moesin peptide (C; pAbKYKTLR) or moesin phosphopeptide antibodies (D; pAbKYKpTLR). The
position of moesin is indicated by the arrow in A. In E, the Coomassie brilliant blue–stained gel shows the protein profile of fractions
containing 558T-p-moesin in the different chromatographic steps: lane 1, total platelet lysate; lane 2, 558T-p-moesin eluted from heparin-
agarose; lane 3, eluate from blue-Sepharose; lane 4, eluate from phenyl-Sepharose; and lane 5, final product after DEAE-cellulose. Molecular
mass standards are shown in A and D. In F, immunoblots of purified 558T-p-moesin and nonphosphorylated (np-) moesin after two-
dimensional electrophoretic separation show homogeneous spots. The blots were developed with monoclonal antibodies to moesin
(mAbMo).
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tants, and the specificity of binding was maintained (Figure
4B). Essentially all of both the 558T-p-moesin (0.5 mM) and
the actin (5 mM) pelleted under these conditions. 558T-p-
moesin co-sedimented equally well with either rabbit skel-
etal a-actin or human platelet b,g-actin (Figure 4C). Binding
in DOTMAC was specific for actin filaments, because neither
purified 558T-p-moesin nor np-moesin co-sedimented with
Taxol-stabilized microtubules, which are also negatively
charged biological polymers (our unpublished results).
Binding in DOTMAC depended solely on the phosphoryla-
tion state of platelet moesin, independent of any other vari-
able in the purification process, because removal of the
phosphate from 558Thr by incubation with a purified platelet
phosphatase eliminated binding to F-actin in this co-sedi-
mentation assay (Hishiya and Nakamura, submitted for
publication).
We further characterized the association between 558T-p-
moesin and F-actin by quantifying the amount of moesin
that co-sedimented with increasing amounts of actin (0.5–5.0
mM) and by quantifying the amount of co-sedimented moe-
sin when the 558T-p-moesin concentration was varied from 1
to 5 mM (Figure 5, A and B). At physiological ionic strength,
558T-p-moesin bound in a saturable manner to F-actin with a
stoichiometry of 1:1, relative to monomeric actin (Figure 5C).
Similar stoichiometries were observed with b,g-actin (our
unpublished results). From Scatchard analyses the dissocia-
tion constant (Kd) for the interaction between p-moesin and
either actin isoform was ;10 nM. We next varied the con-
centration of phosphorylated moesin over the range of
1.5–30 nM, while keeping the actin concentration constant at
200 nM (Figure 5D). No free 558T-p-moesin was detected in
the supernatant even at the lowest p-moesin concentration
(1.5 nM), suggesting that the Kd is ,1.5 nM. An accurate
determination of affinities would require measurements to
be made at protein concentrations at or below the value of
Kd. This is not possible, because 0.5 nM is the detection limit
in this assay system. A Kd on the order of 1029 M is high
compared with other actin-associated proteins (Gilmore and
Burridge, 1996; Roy et al., 1997) and suggests that the rate of
p-moesin dissociation from F-actin is negligibly small under
these conditions.
Finally, we investigated whether the association of 558T-
p-moesin is influenced by np-moesin. As shown in Figure
5E, 558T-p-moesin selectively co-sediments with F-actin
when both forms are mixed together at an equal ratio. This
suggests that unmodified platelet moesin molecules neither
associate with 558T-p-moesin molecules nor interfere with
the binding of 558T-p-moesin to filamentous actin under
these experimental conditions.
Association of Moesin with the DOTMAC-Insoluble
Cytoskeleton is Contingent upon Phosphorylation
of 558T
Thrombin induces platelet aggregation (Schoenwaelder et
al., 1994) caused by increased cell-to-cell contacts that are
mediated by integrins and adhesive proteins (Packham,
1994). This process is associated with a rapid redistribution
of cytoskeletal proteins, as has been shown by the analysis of
nonionic detergent lysates (Fox et al., 1993). Most cytoplas-
mic actin filaments in platelets are recovered in the deter-
gent-insoluble pellet after low-speed centrifugation,
whereas membrane-bound F-actin filaments and membrane
skeleton proteins, such as vinculin or talin, sediment at
much higher speed (Fox, 1993).
The cytoskeletal association of 558T-p-moesin was main-
tained after platelets were extracted with DOTMAC, but not
Figure 3. F-actin blot overlay detects binding to the phosphorylated
form of moesin in platelet lysates and after purification. Proteins were
separated by SDS-PAGE, transferred to nitrocellulose filters, and blot-
ted with a 125I-labeled F-actin probe in A and B and with a [32P]ATP-
labeled probe in C. Before this analysis, the amounts of immunoreac-
tive moesin were estimated by densitometric analysis and comparison
with known amounts of recombinant moesin. The loaded amount of
moesin is indicated in nanograms. (A) Binding of F-actin to purified
recombinant moesin made in bacteria (470 ng; rec moesin, lane 1) and
to purified phosphorylated platelet moesin (500 ng; p-moesin, lane 3).
Nonphosphorylated moesin (498 ng; np-moesin, lane 2) does not bind
appreciably bind to the probe. Parallel blots were processed with
monoclonal moesin antibodies (mAbMo) or with antibodies specific
for phosphorylated moesin (pAbKYKpTLR), indicating comparable
protein loads and lack of detectable phosphorylation signals for rec
moesin and np-moesin. (B) F-actin and antibody blots of total lysates of
resting platelets (lane 1; 496 ng), platelets activated with thrombin for
10 s (lane 2; 502 ng), and platelets treated for 10 min with staurosporine
(483 ng) or calyculin A (497 ng). Note the increase in F-actin signal
intensity caused by thrombin stimulation in comparison with resting
platelets and in relation to the maximal signal detected after calyculin
A pretreatment. This relationship is also apparent from the immuno-
blot with phosphorylation-specific antibodies. (C) The amount of pu-
rified phosphorylated (p-) and nonphosphorylated (np-) moesin and of
the two forms of moesin in platelet lysates of calyculin A-, staurospor-
ine-, and thrombin-treated or resting platelets was quantified by im-
munoblotting and scanning densitometry as described in MATERIALS
AND METHODS. The data shown represent total moesin and p-
moesin in nanograms (total/P). Note again the absence of F-actin
binding to platelet moesin in the absence of phosphorylation and
increased binding signal resulting from the increase in phosphoryla-
tion caused by thrombin stimulation or by calyculin A.
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with Triton X-100. When resting platelets were extracted
with Triton X-100 (Figure 6A, left), ;80–95% of both total
moesin and p-moesin were recovered in the 100K superna-
tant, and only small amounts remained associated with the
cytoskeleton (;5% in the 15K pellet) and membrane skele-
ton (3.2% total moesin in the 100K pellet; Figure 6, B and C).
In contrast, 53.4 6 4.2% (mean 6 SD) of the actin sedimented
in the Triton X-100-insoluble 15,600 3 g pellet of resting
platelets. This amount increased and reached a peak of
78.4 6 2.4% of the total platelet actin within 5 min after
stimulation with thrombin (Figure 6D). This increase was
accompanied by a corresponding loss of actin from the
supernatant fraction (Figure 6D), consistent with an in-
creased incorporation of actin into the cortical cytoskeleton.
Because most of the 558T-p-moesin was soluble even after
calyculin A treatment, which results in essentially complete
phosphorylation of moesin, phosphorylation alone is insuf-
ficient to retain moesin in the Triton X100-insoluble fraction.
When platelets were fractionated with 1% DOTMAC (Figure
6, right), 558T-p-moesin was quantitatively recovered with the
bulk of actin in the 15K cytoskeletal pellet (Figure 6F, right).
The percentage of 558T-p-moesin in this fraction also increased
within seconds after thrombin stimulation (Figure 6F, right),
with kinetics similar to that observed for moesin phosphory-
lation in total platelet lysates (Figure 1C). The amount of 558T-
p-moesin in the 15K pellet also increased after treatment with
calyculin A (Figure 6F, right). By contrast, nearly all the np-
moesin was recovered in the 100K soluble fraction (Figure 6E,
right). Thus, the distributions of p-moesin and np-moesin in
DOTMAC-fractionated platelets suggest that the association of
moesin with the actin-based cytoskeleton in vivo is critically
dependent on phosphorylation of 558Thr in moesin, results
consistent with our observations of phosphorylation-depen-
dent binding to F-actin in vitro.
F-Actin Binding Site of 558T-p-Moesin Exposed by
Phosphatidylinositides
The requirement of a cationic detergent for binding of F-
actin to moesin both in vitro and in vivo suggested that














None 93 60/62 (55/62)
Nonionic
Triton X-100 0.016 0.005 94 3/2 (4/4)
0.1 94 2/2 (3/4)
Tween 20 0.006 0.001 93 0/0 (0/0)
0.1 86 0/0 (0/0)
OG 0.7 0.1 95 2/4 (2/4)
1.0 94 0/4 (0/4)
DMDOAO 0.048 0.01 95 0/0 (0/0)
0.1 96 0/0 (0/0)
Amphoteric
CHAPS 0.5 0.1 70 0/0 (0/0)
1.0 45 0/0 (0/0)
Anionic
SDS 0.24 0.05 0 0/0 (0/0)
1.0 0 0/0 (0/0)
SDSc 0.2 0.05 91 45/95 (47/95)
1.0 48 2/3 (2/2)
Cationic
CETMAC 0.033 0.01 87 0/0 (0/100)d
0.1 14 0/0 (0/5)
DOTMAC 0.4 0.1 81 0/0 (14/85)d
1.0 8 0/0 (0/2)
DOPC 0.04 0.01 95 16/93 (18/94)
0.1 36 0/3 (0/5)
Phosphorylated (p-) or unphosphorylated (np-) moesin isolated from platelets was incubated with detergents in the presence or absence of
actin filaments for 1 h at 37°C before centrifugation. Proteins of supernatant and pellet fractions were quantitated after SDS-PAGE and
Coomassie brilliant blue staining by scanning densitometry. Percent indicates the amount of moesin in pellet fraction. OG, octyl-b-glucoside;
DMDOAO, N,N-dimethyldodecylamine N-oxide; CHAPS, 3-[(cholamidylpropyl)-dimethyl ammonio]-1-propane sulfonate; CETMAC, cetyl-
trimethylammonium chloride; DOPC, dodecylpyridinium chloride.
a Igarashi, 1987.
b Data are presented as mean (n 5 3), and each SD was ,10% of the mean.
c At pH 8.1
d Significant difference between np-moesin and p-moesin by t test (p , 0.001).
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phosphorylation was probably not the only contributing
factor to the regulation and maintenance of moesin’s F-actin-
binding activity. Niggli et al. (1995), Hirao et al. (1996), and
Huang et al. (1999) have shown that moesin-like proteins
bind PI(4)P and PI(4,5)P2. Because both cationic detergent
and anionic lipids might act by disrupting potentially inhib-
itory electrostatic interaction(s), we examined the effects of
charged phospholipids on the sedimentation behavior of the
two forms of platelet moesin. Phospholipids at concentra-
tions of 0.01% (wt/vol) in the form of multilamellar vesicles
(l-a-phosphatidyl-l-serine, l-a-phosphatidylethanolamine,
sphingomyelin, phosphatidylchlorine, phosphatidylglyc-
erol, and phosphatidic acid), alone or in combination, either
increased sedimentation of both forms of moesin (70–80%
with phosphatidylglyceride, .90% with phosphatidic acid)
or had no effect on aggregation or binding activity in that
;60% of both forms of moesin sedimented in both the presence
and absence of F-actin. In the presence of phosphatidylinositi-
des [PI(3)P:diC16:0, PI(4)P, PI(3,4)P2, PI(4,5)P2, and PI(3,4,5)P3:
diC16:0], added as micelles or incorporated into small unila-
mellar vesicles together with phosphatidylcholine, 100% of
both forms of moesin sedimented with or without actin (our
unpublished data), suggesting an association of moesin with
the negatively charged phospholipids. By contrast, moesin in
the absence of actin did not sediment, when stabilized with
mixed micelles of charged phospholipids (PI, PI(4)P, and
PI(4,5)P2) and 0.1% Triton X-100 or 0.01% lysophosphatidyl
choline (Table 2). When F-actin was added to moesin solubi-
lized with Triton X-100 and either PI(4)P or PI(4,5)P2 at a
detergent:phospholipid ratio of 10:1, ;50% of 558T-p-moesin
selectively and specifically co-sedimented with F-actin (Table 2
and Figure 7). No co-sedimentation with F-actin was observed
when PI was substituted for phosphatidylinositide phosphates.
The binding of moesin to PI(4,5)P2 was so tight that this
complex resisted disruption by SDS. This change was ap-
parent as a shift of moesin from its normal migration posi-
tion to slower-migrating species revealed as a smear by
silver staining of the gel (Figure 8A). These products ac-
counted for the loss of moesin from the normal position of
migration, because no material was detected that might have
been trapped on top of the gel. This apparent loss or gel shift
of 78-kDa protein on SDS gels was not as pronounced for
mixtures of moesin with PI and PI(4)P (Figure 8B). Heating
the PI(4,5)P2-moesin mixture for 5–60 min neither increased
nor decreased the loss seen with short incubation times (our
unpublished results). A weak effect reaching statistical sig-
nificance at 60 min was noted, however, when the mixture
was heated in the presence of 0.1% Triton X-100 (our un-
published data), and 1% Triton X-100 or Tween 20 com-
pletely prevented this gel shift in the presence of phospha-
tidylinositol biphosphate (PIP2) apparently because of
disruption of the complex. Thus, gel shift analysis can be
used to demonstrate a direct and specific interaction be-
tween moesin and PI(4,5)P2, as had previously been re-
ported for a-actinin (Fukami et al., 1992).
DISCUSSION
Currently available evidence suggests that members of the
moesin family of proteins interact specifically with actin
Figure 4. Phosphorylated moesin selec-
tively co-sediments with F-actin. (A) Puri-
fied phosphorylated (p-) or nonphospho-
rylated (np-) platelet moesin (0.5 mM) was
incubated either alone or together with
rabbit skeletal a-F-actin (5 mM) in DOT-
MAC-containing buffer for 1 h at 25°C
before centrifugation, as described in MA-
TERIALS AND METHODS. Equal vol-
umes of supernatant (S) and pellet (P) frac-
tions were analysed by SDS-PAGE, and
proteins were visualized by Coomassie
brilliant blue staining. The top band cor-
responds to moesin; the bottom band is
actin. In the absence of actin, all of the
moesin remains in the supernatant. Mixed
with F-actin, a large fraction of p-moesin,
but only a small fraction of np-moesin,
co-sediments and appears in the pellet
fraction. As can be seen, a fraction of actin
remains in the supernatant, presumably
because of a DOTMAC-induced increase
in critical concentration for actin polymer-
ization. When phalloidin is added to sta-
bilize F-actin, essentially all of the actin is
pelleted; p-moesin, but not np-moesin co-
sediments with these phalloidin-stabilized
filaments (B). (C) Under identical co-sedi-
mentation conditions, p-moesin sediments
equally well with skeletal muscle a- and
platelet b, g-actin.
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filaments. This is most readily demonstrated with C-termi-
nal fragments, which co-distribute with actin filaments and
stress fibers in cells (Algrain et al., 1993; Matsui et al., 1998;
Amieva et al., 1999) and which bind directly to F-actin in
solution binding assays (Turunen et al., 1994, Pestonjamasp
et al., 1995; Huang et al., 1999). Detection of the F-actin
binding activities of full-length, native proteins has been
more difficult. This has not been directly demonstrated as
yet in vivo, and several in vitro studies yielded remarkably
discrepant results. Using co-sedimentation binding assays,
Yao et al. (1996) determined a Kd of 50 nM, a stoichiometry
of 1 ezrin bound for every 10 actin monomers, and isoform
specificity for b-actin. This form of ezrin contains phospho-
serine (Urushidani et al., 1989; Hanzel et al., 1991). Using
bacterially expressed ezrin and a solid-phase assay, Roy et al.
(1997) obtained a Kd of 504 6 230 nM, a stoichiometry of 1 to
10.6 actin monomers, and approximately identical binding
with filaments of a- or b/g-actin. F-actin required both N-
and C-terminal residues. A second site(s), which bound both
F- and G-actin, was mapped between residues 288 and 333.
By contrast, blot overlays and co-sedimentation assays with
F-actin and in vitro–translated moesin indicated that only
the C-terminal domains of moesin, ezrin, and radixin inter-
act with F-actin (Huang et al., 1999); no binding to G-actin
was observed (Pestonjamasp et al., 1995). Simons et al. (1998)
phosphorylated a mixture of partially purified proteins in
vitro at a ratio of 1 in 10 molecules presumably including
threonine residues (Pietromonaco et al., 1998). From their
co-sedimentation data, Simons et al. (1998) calculated Kd
values of 1.8 and 5 mM for moesin and ezrin, respectively,
and found no isotype specificity.
Because of these discrepancies, we thought it important to
isolate moesin from a cellular source. By taking advantage of
previous work on platelets, we have been able to character-
ize two forms of moesin that differ only with respect to
phosphorylation at a single residue (Nakamura et al., 1995).
This has made it possible to critically address the questions
of whether and how the physiologically relevant phosphor-
ylation at a conserved C-terminal residue, 558threonine, in-
fluences the F-actin binding potential of moesin and related
proteins.
Our current interpretation of the cumulative data, includ-
ing those presented here, is that the F-actin binding potential
of full-length, cellular moesin in vitro is assay dependent
Figure 5. Phosphorylated moesin binds to filamentous actin with high affinity and at a ratio of 1:1. To define dissociation constants for the
specific interaction between actin filaments and p-moesin in DOTMAC, co-sedimentation was done by keeping the p-moesin concentration
fixed at 2 mM and varying the actin concentration from 0.5 to 5 mM (A) and by varying the p-moesin concentration from 1–5 mM at a fixed
2 mM concentration of actin (B). (C) Saturation binding analysis of p-moesin and a-actin at the micromolar level. Data were obtained under
conditions described in B and are the mean 6 SD of three separate measurements. p-Moesin was varied over the range shown, whereas actin
concentration was constant at 2 mM. (D) Binding analysis of p-moesin and a-actin at the nanomolar level. p-Moesin was varied over the range
shown, whereas actin concentration was constant at 200 nM. Data are the mean 6 SD of three separate measurements derived from
immunoblots probed with moesin antibodies. (E) Indicated amounts of p- and np-moesin were mixed before addition to actin filaments and
centrifugation. The Western blot, developed with monoclonal antibodies to moesin (mAbMo) and p-moesin antibodies (pKYKpTLR), shows
the distribution of the two moesin forms in supernatants (S) and pellets (P). Note that both forms remain in the supernatant in the absence
of F-actin; all detectable p-moesin co-sediments with F-actin; increasing the amount of p- and np-moesin in the mixture yields expected
amounts of p-moesin in the pellets, and np-moesin does not sediment as a mixed aggregate of p- and np-moesin.
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and that phosphorylation of 558threonine is one critical re-
quirement. The blot overlay assay clearly distinguishes be-
tween phosphorylated and nonphosphorylated platelet
moesin, with F-actin binding preferentially to phosphory-
lated platelet moesin. However, moesin made in bacteria
also binds radiolabeled actin despite the fact that it is not
phosphorylated. We have quantified this interaction by as-
suming that all p-moesin molecules measured with phos-
phorylation state-specific antibodies bind F-actin, whereas
np-moesin does not. The data suggest that ;30% of recom-
binant moesin reacts with the F-actin probe. Experimentally,
we can show that treating moesin with acetone effectively
converts platelet np-moesin to an F-actin binding form and
enhances binding of the recombinant moesin. Similarly, boil-
ing of cellular moesin, ezrin, or radixin in gel sample buffer
containing SDS and dithiothreitol enhances their subsequent
ability to bind F-actin in blot overlay assays. Furthermore,
the isolated C-terminal domain binds actin constitutively,
and phosphorylation or substitution of 558threonine does not
change this activity (Matsui et al., 1998; Huang et al., 1999).
These observations suggest that factors in addition to phos-
phorylation influence binding to the full-length proteins in
this assay. The best explanation is incomplete or different
folding during biosynthesis and/or analysis of the recombi-
Figure 6. Phosphorylation-dependent association of moesin with the DOTMAC-insoluble cytoskeleton in thrombin-activated platelets.
Platelets were lysed with Triton X-100 (left panels) or DOTMAC (right panels) lysis buffer at the indicated times (0 and 10 s and 5 min) after
stimulation with 1 NIH unit/ml human thrombin at 37°C. Platelets were also incubated with 100 nM calyculin A (CA) or 1 mM staurosporine
(ST) for 10 min before thrombin activation for 10 min. Lysates were centrifuged for 4 min at 15,600 3 g, and the first supernatants were
centrifuged for a further 30 min at 100,000 3 g. Low- and high-speed pellets and high-speed supernatants were solubilized in SDS sample
buffer, and the proteins were resolved by SDS-PAGE on a 9% gel and transferred to nitrocellulose membranes. (A) Coomassie brilliant
blue–stained gels of the Triton X-100 (left) and DOTMAC (right) extraction and fractionation. After transfer of the proteins to nitrocellulose,
blots were incubated with polyclonal antibodies to moesin (pAb-moesin; B) or phosphorylated moesin (pAb-p-moesin; C). Relative amounts
of actin (D), moesin (E), and phosphorylated moesin (F) were obtained by densitometric analysis of the gels shown in A and the
corresponding immunoblots of B and C. The blots shown in B and C are representative of three separate experiments. The data presented
in D–E represent the means 6 SD of three separate measurements. For detailed description and explanation, see text.
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nant and partial denaturation of mammalian proteins by
SDS or acetone.
We found that small amounts of detergents are needed to
prevent moesin from aggregating in solution and to permit
the study of the interaction of purified platelet moesin with
actin filaments by co-sedimentation binding assays. Minimi-
zation of aggregation and maintenance of F-actin binding
are experimentally separable in that many detergents appar-
ently stabilize moesin against aggregation without support-
ing binding to F-actin. Co-sedimentation of moesin with
F-actin in solution binding assays apparently requires both
phosphorylation of 558threonine and the presence of highly
charged lipids. Both the cationic detergent DOTMAC and
phosphatidylinositides support the binding of p-moesin, but
not np-moesin, to actin filaments. Phosphorylation is critical
because the quantifiable removal of the phosphate group by
a purified platelet phosphatase renders moesin inactive.
Concentrations of DOTMAC that stabilize moesin against
aggregation and also support phosphorylation-dependent
binding to F-actin induce bundling of actin filaments, when
analyzed by negative-staining electron microscopy (our un-
published results). Actin filament stability is not affected,
except at much higher concentrations of DOTMAC. Because
DOTMAC-solubilized np-moesin does not bind to actin fil-
aments, DOTMAC apparently does not simply expose the
F-actin binding site by denaturation, as we are proposing
happens with acetone-mediated denaturation. Although the
length of the hydrocarbon chains influences the effective
concentration at which this detergent is active, its primary
effect is probably through an interaction of the positively
charged detergent head group with one or more of the
highly conserved clusters of negatively charged amino acid
Figure 7. Phosphatidylinositol 4,5-biphosphate is required for F-actin binding of phosphorylated moesin in Triton X-100. Phosphorylated
(p-) and non-phosphorylated (np-) moesin isolated from platelets was incubated alone or in the presence of a-actin for 1 h at 37°C before
sedimentation. In A, no detergent was added, and sizable fractions (;60%) of p- and np-moesin sedimented and were recovered in the pellet
together with actin. There was no apparent difference between the two forms of moesin. In B, 0.1% Triton X-100 was added to the reaction
mixtures. Both forms of moesin were soluble and did not sediment under this condition. In C and D, mixed micelles of 0.1% Triton X-100
and 0.01% phosphatidylinositol (PI) or phosphatidylinositol 4,5-biphosphate (PIP2) were added to the reaction mixtures. Approximately 50%
of the total p-moesin co-sedimented together with actin in the presence of PIP2. In all experiments, equal volumes of supernatant (S) and pellet
(P) fractions were analysed by SDS-PAGE and Coomassie blue staining.
Table 2. Summary of the effect of detergents, lipids, or detergent-mixed micelles on solubility of moesin and association of moesin with







in pellet with F-actin (%)
None 60/62 (55/62)
Triton X-100 0.1 2/2 (3/4)
Triton X-100 1 PI 0.1/0.01 3/3 (4/5)
Triton X-100 1 PI(4)P 0.1/0.01 3/4 (5/47)*b
Triton X-100 1 PI(4,5)P2 0.1/0.01 5/8 (7/45)*b
LysoPC 0.01 0/0 (3/4)
LysoPC 1 PI 0.01/0.01 2/3 (5/4)
LysoPC 1 PI(4,5)P2 0.01/0.01 5/5 (7/22)**b
Phosphorylated (p-) or non-phosphorylated (np-) moesin isolated from platelets was incubated with detergents or detergent-mixed micelles
in the presence or absence of actin filaments for 1 h at 37°C before centrifugation. Proteins in supernatants and pellets were quantitated after
SDS-PAGE and Coomassie brilliant blue staining by scanning densitometry. Percent indicates the amount of moesin in pellet fraction. F-actin
was stable in all conditions.
a Data are presented as mean (n 5 3) and each SD was ,10% of the mean.
b Significant difference between np-moesin and p-moesin by t test (* p , 0.001; ** p , 0.01).
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residues in moesin (Lankes et al., 1993). The binding constant
between F-actin and moesin in DOTMAC is high in com-
parison with other actin-binding proteins, and we estimated
the stoichiometry to be 1 moesin bound to 1 actin monomer.
The magnitude of these values may be influenced by the
bundling effect of DOTMAC on actin filaments.
We suggest that PI(4)P and PI(4,5)P2 promote selective
F-actin binding to p-moesin by binding tightly to moesin,
because both p- and np-moesin are stabilized against aggre-
gation or complex formation by these lipids below threshold
concentrations (our unpublished results). Although binding
constants for the interactions of polyphosphatidylinositides
with moesin still need to be established, these negatively
charged lipids are better candidates for physiological effec-
tors than are positively charged lipids, which have not been
reported in mammalian cells.
Polyphosphatidylinositides have been shown to regulate
the activities of various other actin-binding proteins (Furu-
hashi et al., 1992; Janmey, 1994) and to affect protein struc-
ture. For example, PIP2 increases the a-helix content of
profilin (Ragunathan et al., 1992) and induces conforma-
tional changes of peptides (Lu and Chen, 1997). PIP2 also
dissociates the head–tail interaction of vinculin, unmasking
its talin and actin binding sites (Gilmore and Burridge,
1996). Thus, binding of PIP2 to sites on the N-terminal do-
main of moesin (Niggli et al., 1995) could affect intramolec-
ular structural features, as discussed below.
Mechanism of Activation of F-Actin Binding
The best explanation for the activation of F-actin binding of
moesin is a conformational change caused by phosphoryla-
tion, cationic detergents, and polyphosphatidylinositides.
Previously published data suggest the existence of a binding
interaction between N- and C-terminal regions of ezrin,
radixin, and moesin in the full-length, undenatured protein.
This interaction has been demonstrated by in vitro assays
with bacterially expressed GST fusion peptides of ezrin and
radixin (Gary and Bretscher, 1995; Magendantz et al., 1995),
and by the yeast two-hybrid method with tagged and un-
tagged fragments of moesin (Huang et al., 1999). Recent
structural data derived for a co-crystal of N- and C-terminal
domains of moesin also indicate that two of three subregions
of the N-terminal domain contact the C-terminal domain
(Pearson et al., 1998). Phosphorylation of 558threonine in the
C-terminal domain inhibits the interaction with the N-ter-
minal domain (Matsui et al., 1998). Substitution of 558threo-
nine with aspartate has the same effect (Huang et al., 1999),
indicating that a single negative charge is sufficient to pre-
vent interaction. Indirect evidence is also provided by the
much stronger binding of p-moesin to heparin in compari-
son with np-moesin. This constituted the basis for the suc-
cessful separation of the two forms of moesin (Figure 3). The
behavior of p-moesin during isolation is consistent with the
exposure of additional positively charged residues to hepa-
rin and a structural change that is certainly larger than one
would have expected from the additional single negative
charge in p-moesin. The implication of these results for the
intact protein is that structural disruption directly exposes
the region of moesin that contains the F-actin binding site.
Although previously proposed (Gary and Bretscher, 1995;
Bretscher, 1999), this mechanism has not been formally es-
tablished for the intact protein. Our experiments with iso-
lated cellular proteins in vitro are consistent with the pro-
posed activation of F-actin by disruption of the interaction
between the N- and C-terminal domains, but our data also
point toward additional contributory factors.
Evidence for a relatively large change in conformation
comes from model studies with moesin mutants translated
in vitro. Gary and Bretscher (1995) have shown that N- and
C-terminal domains of recombinant ezrin associate with
full-length denatured ezrin in vitro. According to their hy-
pothesis, this is explained by the exposure of nondenatured
F-actin binding sites through denaturation of N-terminal
inhibitory sequences. We have compared full-length wild-
type, Thr558Asp and various deletion mutant moesins for
binding to N- and C-terminal domain probes (Huang et al.,
1999). In several assays, the ability of the full-length mutant
to bind an additional domain of moesin parallels its F-actin
binding activity. Binding of a relatively large 30-kDa peptide
to the full-length protein requires a rather dramatic change
in structure. Furthermore, when present, PIP2 inhibits the
interaction of the C-terminal domain to the full-length
Thr558Asp mutant. This suggests that PIP2 acts cooperatively
and in concert with phosphorylation to expose the F-actin
binding site.
Role and Regulation of Moesin Phosphorylation
in Cells
How does phosphorylation of moesin contribute to cellular
events during platelet activation? Thrombin-induced plate-
let shape change and secretion parallel the rapid increase in
phosphorylation of a number of proteins (Fox, 1993; Holm-
sen and Dangelmaier, 1989). The phosphorylation of these
Figure 8. Gel shift induced by binding of phosphatidylinositol
4,5-biphosphate to moesin on SDS polyacrylamide gels. Phosphor-
ylated or nonphosphorylated moesin (0.5 mg) was incubated with
sonicated PI, PI(4), PI(4,5)P2, or LysoPC (lysophosphatidylcholine)
in 10 ml of buffer F (final concentration, 0.02%, wt/vol) for 1 h at
37°C. In some experiments, 0.1% Triton X-100 or LysoPC was
added, and the incubation was continued for an additional 1 h. The
solutions were then solubilized with an equal volume of 23 SDS
sample buffer and run on a 9% polyacrylamide gel under reducing
conditions. Proteins were stained with the silver method. (A) An
example is shown for moesin and PI(4,5)P2. Note the lower intensity
of the band in the normal migration position. (B) The reduction in
moesin under various conditions has been quantified by densitom-
etry. The graph shows this loss as an indication of the gel shift that
occurred in the presence of PI(4,5)P2. This shift in migration is
weakly influenced by a 60-min incubation in 0.1% Triton X-100 or
LysoPC but is completely reversed in 1% Triton X-100.
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proteins occurs in three temporal phases that can be exper-
imentally distinguished (Ferrell and Martin, 1988). First, the
early phosphorylation of proteins such as P-selectin (Crov-
ello et al., 1993), actin-binding protein (Carroll and Gerrard,
1982), myosin light chains (Fox and Phillips, 1982), and
p60src (Clark and Brugge, 1993) occurs by an inte-
grin-independent mechanism. Fibrinogen, by binding to the
integrin receptor aIIbb3 (GPIIbIIIa), initiates a second wave
of phosphorylation, which is followed by a third wave of
platelet aggregation-dependent phosphorylation of proteins
such as FAK (Lipfert et al., 1992). Kinetic data suggest that
moesin is one of protein substrates in the first wave of
phosphorylation.
In platelets, signaling occurs primarily through members
of the seven transmembrane–heterotrimeric G protein–cou-
pled family of receptors (Zhang et al., 1993; Chong et al.,
1994; Benka et al., 1995) and through adhesion receptors
(Torti et al., 1994). As an effector of heterotrimeric G proteins,
Rho acts on several targets, including Rho-dependent ki-
nases and phosphatases. Moesin may be one of the targets
for these enzymes. Rho-dependent kinase, however, does
not efficiently modify the full-length protein in vitro, al-
though recombinant C-terminal sequences of radixin are
readily phosphorylated by this enzyme (Matsui et al., 1998).
Rac, Cdc42, and Rho also regulate phosphatidylinositide
metabolism (Chong et al., 1994; Carpenter et al., 1997), and
PIP2 and Rho-dependent signaling pathways have been im-
plicated in the association of moesin to plasma membrane
constituents (Hirao et al., 1996).
Our new insights regarding the requirements for the in-
teraction of moesin with F-actin provide an opportunity to
reevaluate these data. The incomplete information currently
available does not make it clear which interactions are reg-
ulated, when, where, and by whom. For example, does PIP2
primarily regulate interactions with membrane proteins,
does it primarily regulate F-actin binding, or both? We also
do not yet know whether 558Thr phosphorylation is required
to activate moesin before binding to membrane proteins. We
could envision dual effects and mechanisms in which PIP2,
by stabilizing interactions with membrane proteins, also
presents moesin in a favorable conformation to be acted on
by phosphokinases (Figure 9). We have attempted to recon-
stitute such a system in vitro with purified np-moesin, cy-
toplasmic fragments of CD44 that are known to associate
with recombinant moesin, and PIP2 (Hirao et al., 1996; Legg
and Isacke, 1998). However, we were not able to demon-
strate binding of the CD44 cytoplasmic domain to either
form of platelet moesin. This failure may derive from struc-
tural differences between platelet and recombinant moesin,
or it may be due to the requirement for other, as yet uniden-
tified regulatory components. These experiments did reveal,
however, that F-actin binding of np-moesin was not acti-
vated, emphasizing the important role of phosphorylation.
The reported redistribution of receptors (Helander et al.,
1996; Serrador et al., 1997), formation of cell surface micro-
extensions (Lamb et al., 1997; Shaw et al., 1998), and cell–cell
interactions (Crepaldi et al., 1997) mediated by moesin, ezrin,
and radixin may depend on the proposed multistep mech-
anism of activation (Figure 9). Regulated binding to F-actin
may serve to recruit receptors into filopodia; to create ten-
sion in the case of receptors attached to extracellular ligands
(Zhang et al., 1997), to redistribute receptors via treadmilling
of actin filaments or through the action of myosin motors
(Mitchison and Kirschner, 1988), and/or to retrieve mem-
brane during retraction of cell surface extensions (Amieva et
al., 1998). One could speculate that phosphorylation of res-
idues other than 558Thr serves similar functions, but this
needs to be evaluated (Krieg and Hunter, 1992; Fazioli et al.,
1993; Chen et al., 1995). Our model allows recruitment to the
membrane of moesin and other proteins to be regulated
independently of F-actin attachment and provides a mech-
anism for ensuring tight spatial and temporal control of
F-actin recruitment. It will be of some interest to test this
model in cells, because changes at the membrane–cytoskel-
etal interface form an important part of cellular responses
and may require more than one signal.
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